TSOI — Therapeutic Solutions International Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $1.26m
- $0.10m
Brief: Therapeutic Solutions International Files To Initiate Phase Iii Clinical Trial For Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive Covid-19 Data With Jadicell Stem Cell Therapy
Brief: Therapeutic Solutions International Files With FDA To Expand Ongoing Phase III Clinical Trial To Include All Causes Of Acute Respiratory Distress Syndrome
Brief: Therapeutic Solutions Granted Emergency IND By FDA For Stem Cell Therapy
Brief: Therapeutic Solutions International Completes Purchase Of FDA Phase Iii Jadicell Stem Cell Investigational New Drug Application From University Of Miami
Brief: Therapeutic Solutions International Announces Reduction Of Covid-19 Associated Cognitive Decline By Quadramune Nutraceutical In Animal Model
Brief: Therapeutic Solutions International Identifies And Files Patent On Novel Mechanism Of Action Of Its Jadicell™ Treatment Of Covid-19 And Delta Variant
Brief: Therapeutic Solutions International Prepares To Apply For EUA For Its FDA Phase Iii Covid-19 Stem Cell Therapy Jadicell™
Brief: Press Release - Therapeutic Solutions International Approved On Rangeme To Sell Quadramune™ And Nanostilbene™ Along With Other Supplements
Brief: Therapeutic Solutions International Files Investigational New Drug Application With FDA For Treatment Of Chronic Traumatic Encephalopathy Using Clinically Validated Jadicell® Universal Donor Stem Cell
Brief: Therapeutic Solutions Says It Will Use Clinical Stage Cancer Immunotherapy For Covid-19
Brief: Therapeutic Solutions Reports Reduction Of Brain Inflammation/Depression Associated Biochemical Pathway Using Quadramune
Brief: Therapeutic Solutions International Collaborates With Right To Try Foundation On Novel Means Of Protecting Patients While Hyper-Accelerating Drug Development
Brief: Therapeutic Solutions International Reports Its Nanostilbene Nutraceutical Product Enhances Efficacy Of Cancer Immunotherapy In Animal Model Of Cancer
Brief: Therapeutic Solutions Adds Nano Cannabidiol To Nanomyros For Inhibition Of Microvesicle And Exosome Release In Prostate Cancer
Brief: Therapeutic Solutions To Initiate Clinical Trial Of Cancer Immunotherapy Adjuvant Nanostilbene